HETEROCYCLIC COMPOUNDS AND USE THEREOF
Disclosed are heterocyclic compounds of Formula (l). (see formula I) Also disclosed is a pharmaceutical composition containing one of the heterocyclic compounds. Further disclosed are methods of using one of the heterocyclic compounds for mobilizing hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation, and for treating tissue injury, cancer, inflammatory disease, and autoimmune disease..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 31. Aug. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SHIA KAK-SHAN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-08-31, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 |
|---|
| Patentnummer: |
CA3047146 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA006703925 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006703925 | ||
| 003 | DE-627 | ||
| 005 | 20240126102620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA006703925 | ||
| 035 | |a (EPA)CA3047146 | ||
| 035 | |a (EPA)62839630 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SHIA KAK-SHAN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HETEROCYCLIC COMPOUNDS AND USE THEREOF |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-08-31, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 | ||
| 520 | |a Disclosed are heterocyclic compounds of Formula (l). (see formula I) Also disclosed is a pharmaceutical composition containing one of the heterocyclic compounds. Further disclosed are methods of using one of the heterocyclic compounds for mobilizing hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation, and for treating tissue injury, cancer, inflammatory disease, and autoimmune disease. | ||
| 650 | 4 | |a C07F: Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (metal-containing porphyrins c07d0487220000;macromolecular compounds c08) | |
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WU CHIEN-HUANG |4 aut | |
| 700 | 0 | |a SONG JEN-SHIN |4 aut | |
| 700 | 0 | |a WANG YUN |4 aut | |
| 700 | 0 | |a SHIH CHUAN |4 aut | |
| 700 | 0 | |a CHOU MING-CHEN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 31. Aug. |
| 773 | 1 | 8 | |g year:2021 |g day:31 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/62839630/publication/CA3047146A1?q=CA3047146 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 31 |c 08 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 31 |c 08 | ||